Holen Sie sich die Stockscreener-App
0.7449
6.97%
0.0489
Calidi Biotherapeutics Inc Aktie (CLDI) Neueste Nachrichten
What drives Calidi Biotherapeutics Inc. stock priceDouble or triple returns - Autocar Professional
What analysts say about Calidi Biotherapeutics Inc. stockUnmatched market performance - Autocar Professional
Calidi Biotherapeutics Inc. Stock Analysis and ForecastRapid return acceleration - jammulinksnews.com
Is Calidi Biotherapeutics Inc. a good long term investmentDynamic investment opportunities - jammulinksnews.com
40-Year Biotech Veteran Jim Schoeneck Joins Connect Biopharma Board as Asthma Drug Enters Critical Phase - Stock Titan
Calidi Biotherapeutics Invites Investors to Webinar on Precision Genetic Medicine Advances - Nasdaq
Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on July 24 - GlobeNewswire
What risks could impact Calidi Biotherapeutics Inc. stock performanceFree Stock Trading Community - Newser
What makes Calidi Biotherapeutics Inc. stock price move sharplyFree Professional Portfolio Management - Newser
Why Calidi Biotherapeutics Inc. stock attracts strong analyst attentionFree Best Performing Stock Suggestions - Newser
How Calidi Biotherapeutics Inc. stock performs during market volatilityMarket Beating Strategy - Newser
Calidi Biotherapeutics Inc Inc. (CLDI) Price Performance: A Comparative Analysis with Competitors - investchronicle.com
Calidi Biotherapeutics Approves Key Proposals at Annual Meeting - TipRanks
Calidi Biotherapeutics Plummets 27%—Can Biotech Breakthroughs Stem the Slide? - AInvest
Calidi Biotherapeutics Plunges 4.81% Amid Bridge Financing - AInvest
Top Penny Stocks To Add to Your Watchlist – July 9th - Defense World
Small Cap Stocks Worth Watching – July 9th - Defense World
Calidi Biotherapeutics Announces Inducement Offer Agreement - TipRanks
Cancer Innovation Accelerates as Funding Cuts Loom and Biotechs Step Up - Quantisnow
Calidi Biotherapeutics: Redefining Cancer Treatment with Breakthrough Virotherapy - AInvest
Calidi Biotherapeutics Inc. (NYSE American: CLDI) Platform Designed to Transform Landscape of Cancer Treatment - The Manila Times
Breakthrough Cancer Treatment: Calidi's New Genetic Platform Targets Both Primary and Metastatic Tumors - Stock Titan
3 Penny Stocks to Watch Now, 7/10/25 - TipRanks
Calidi Biotherapeutics Cashes In On Warrant Agreement - Finimize
Calidi Biotherapeutics secures $4.6 million through warrant exercise - Investing.com Australia
Calidi Biotherapeutics secures $4.6 million through warrant exercise By Investing.com - Investing.com Nigeria
Calidi Biotherapeutics to Raise $4.6 Million Through Warrant Exercise Agreement - MarketScreener
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers - The Malaysian Reserve
Calidi Biotherapeutics Announces Exercise of Warrants for $4.6 Million of Gross Proceeds - The Manila Times
4.79%
0.12%
Kapitalisierung:
|
Volumen (24h):